18889881171
Kalkine 0
countryflagUS
L

AAPL 208.72 0.168% MSFT 388.5148 0.3137% NVDA 110.49 3.8147% GOOGL 162.58 2.0718% GOOG 164.7 2.0004% AMZN 187.93 0.7451% META 545.87 2.3858% AVGO 191.75 1.9134% LLY 870.695 1.2754% TSLA 285.6351 10.0671% TSM 164.7921 0.3728% V 334.98 -0.2174% JPM 243.11 -0.6254% UNH 418.56 -1.3412% NVO 61.81 -1.3093% WMT 94.725 -1.1634% LVMUY 114.14 -0.105% XOM 108.25 -0.3498% LVMHF 566.0 0.7347% MA 532.36 -0.5789%
AAPL 208.72 0.168% MSFT 388.5148 0.3137% NVDA 110.49 3.8147% GOOGL 162.58 2.0718% GOOG 164.7 2.0004% AMZN 187.93 0.7451% META 545.87 2.3858% AVGO 191.75 1.9134% LLY 870.695 1.2754% TSLA 285.6351 10.0671% TSM 164.7921 0.3728% V 334.98 -0.2174% JPM 243.11 -0.6254% UNH 418.56 -1.3412% NVO 61.81 -1.3093% WMT 94.725 -1.1634% LVMUY 114.14 -0.105% XOM 108.25 -0.3498% LVMHF 566.0 0.7347% MA 532.36 -0.5789%

small-cap

Update on One NASDAQ- Listed Health Technology Stock Amid Market Uncertainty: MDAI

Apr 10, 2025 | Team Kalkine
Update on One NASDAQ- Listed Health Technology Stock Amid Market Uncertainty: MDAI
Image source: Shutterstock

MDAI:NASDAQ
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (US$)

Spectral AI, Inc

Spectral AI, Inc (NASDAQ: MDAI) is a predictive AI company specializing in medical diagnostics aimed at improving the speed and accuracy of treatment decisions in wound care. Its initial focus includes applications for patients with burns and diabetic foot ulcers.

As per our previous US Dailies Report published on ‘MDAI’ on March 31, 2025, Kalkine provided an ‘Buy’ stance on the stock at USD 1.17 based on technical analysis and the stock price has now moved up by ~6.86% since then.

Noted below are the details of support and resistance levels provided in our previous report:                      

Xxxxxx Xxxxxx Xxxxxx

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx

  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx
  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .   

Interested?

Enter your details below and our team will help you to decide if this product is best for you.
  • Australia+61
  • Canada+1
  • India (भारत)+91
  • New Zealand+64
  • United Kingdom+44
  • United States+1
By submitting my details and clicking on the button below, I agree to Kalkine’s Terms and Conditions and Privacy Policy.
I agree to receive marketing calls from Kalkine on the phone number I have provided above. I understand and agree that these calls may be placed using an auto-dialer and that my consent is not a condition of any purchase.
Please wait processing your request...
Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Mid-Cap
One NYSE- Listed Aerospace & Defense Stock at Decent Technical Levels – Archer Aviation Inc
Apr 25, 2025 Team Kalkine
Mid-Cap
Technical Analysis on One NASDAQ- Listed Bitcoin Mining Stock- RIOT
Apr 25, 2025 Team Kalkine
Small-Cap
Technical Analysis on One NYSE- Listed Healthcare Stock- AZTR
Apr 25, 2025 Team Kalkine
Mid-Cap
Update On One US- Listed ETF: NVDL
Apr 25, 2025 Team Kalkine
Small-Cap
Watch Out for One NASDAQ- Listed Biotechnology Services Stock – Inotiv Inc
Apr 25, 2025 Team Kalkine